SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-092576
Filing Date
2020-08-10
Accepted
2020-08-10 12:51:24
Documents
92
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q casi-20200630x10q.htm   iXBRL 10-Q 1648269
2 EXHIBIT 31.1 casi-20200630xex31d1.htm EX-31.1 9967
3 EXHIBIT 31.2 casi-20200630xex31d2.htm EX-31.2 10285
4 EXHIBIT 32.1 casi-20200630xex32d1.htm EX-32.1 6694
5 EXHIBIT 32.2 casi-20200630xex32d2.htm EX-32.2 6729
  Complete submission text file 0001104659-20-092576.txt   6900863

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA casi-20200630.xsd EX-101.SCH 64234
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20200630_cal.xml EX-101.CAL 58315
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20200630_def.xml EX-101.DEF 183886
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20200630_lab.xml EX-101.LAB 419232
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20200630_pre.xml EX-101.PRE 393195
11 EXTRACTED XBRL INSTANCE DOCUMENT casi-20200630x10q_htm.xml XML 1183462
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 201088323
SIC: 2836 Biological Products, (No Diagnostic Substances)